These findings suggest that while GLP-1 medications produce generalized fat loss throughout the body, abdominal fat deposits appear to respond as part of this overall weight reduction, likely due to the metabolically active nature of visceral adipose tissue
93, n o 9, 41704174 (ISSN 0027-8424 et 1091-6490, PMID 8633035, PMCID PMC39506, DOI 10.1073/pnas.93.9.4170, lire en ligne, consult le Biochemical Pharmacology 47: 21132123, 1994 Annual Reviews of Biochemistry 52: 711760, 1983 Journal of Clinical Epidemiology 47: 10211026, 1994 The Lancet 344: 796798, 1994 Ganesaratnam K
Weighted Cox proportional hazard regression was used to estimate hazard ratios (HR) and 95% CI of mortality risk
[11] Saxenda (liraglutide) [prescribing information]